Main Predictions Topic Discovery Antistress
🇬🇧 English 🇪🇸 Español 🇩🇪 Deutsch 🇫🇷 Français 🇵🇱 Polski 🇨🇿 Česky 🇨🇳 中文 🇰🇷 한국어

Articles by tag: phase-2-trial

mRNA vaccine against glioblastoma: 42% survival in phase 2

mRNA vaccine against glioblastoma: 42% survival in phase 2

Personalized mRNA vaccine showed 42% 18-month recurrence-free survival in glioblastoma. Learn details of the breakthrough JAMA study and prospects of the method.